Cargando…

Reduced acute myocardial ischemia–reperfusion injury in IL-6-deficient mice employing a closed-chest model

OBJECTIVE AND DESIGN: We examined the role of IL-6 in the temporal development of cardiac ischemia–reperfusion injury employing a closed-chest I/R model. MATERIALS/METHODS: Infarction, local and systemic inflammation, neutrophil infiltration, coagulation and ST elevation/resolution were compared bet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jong, Willeke M. C., ten Cate, Hugo, Linnenbank, André C., de Boer, Onno J., Reitsma, Pieter H., de Winter, Robbert J., Zuurbier, Coert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841857/ https://www.ncbi.nlm.nih.gov/pubmed/26935770 http://dx.doi.org/10.1007/s00011-016-0931-4

Ejemplares similares

Pharmacological Cardioprotection against Ischemia Reperfusion Injury—The Search for a Clinical Effective Therapy
por: Wang, Qian, et al.
Publicado: (2023)

Experimental parameters and infarct size in closed chest pig LAD ischemia reperfusion models; lessons learned
por: Silvis, Max J. M., et al.
Publicado: (2021)

NLRX1 Deletion Increases Ischemia-Reperfusion Damage and Activates Glucose Metabolism in Mouse Heart
por: Zhang, Hong, et al.
Publicado: (2020)

Partial hexokinase II knockout results in acute ischemia–reperfusion damage in skeletal muscle of male, but not female, mice
por: Smeele, Kirsten M., et al.
Publicado: (2010)

Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces Infarct Size in Presence of Fentanyl, Midazolam and Cangrelor, but Not Propofol
por: Xiao, Yang, et al.
Publicado: (2021)

The Redox Modulating Sonlicromanol Active Metabolite KH176m and the Antioxidant MPG Protect Against Short-Duration Cardiac Ischemia-Reperfusion Injury
por: Xiao, Yang, et al.
Publicado: (2021)

Does acute treatment of dapagliflozin reduce cardiac infarct size through direct cardiac effects or reductions in blood glucose levels?
por: Zuurbier, Coert J.
Publicado: (2020)

Lack of cardioprotection from subcutaneously and preischemic administered Liraglutide in a closed chest porcine ischemia reperfusion model
por: Kristensen, Jens, et al.
Publicado: (2009)

Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning
por: Ferdinandy, Péter, et al.
Publicado: (2023)

Reducing mitochondrial bound hexokinase II mediates transition from non-injurious into injurious ischemia/reperfusion of the intact heart
por: Nederlof, Rianne, et al.
Publicado: (2017)

Fibroblast growth factor 2 is an essential cardioprotective factor in a closed‐chest model of cardiac ischemia‐reperfusion injury
por: House, Stacey L., et al.
Publicado: (2015)

Use of sodium-glucose cotransporter-2 inhibitors and the risk for sudden cardiac arrest and for all-cause death in patients with type 2 diabetes mellitus
por: Eroglu, Talip E, et al.
Publicado: (2022)

Effects of Exogenous Recombinant APC in Mouse Models of Ischemia Reperfusion Injury and of Atherosclerosis
por: Wildhagen, Karin C. A. A., et al.
Publicado: (2014)

Editorial: Diabetes and Heart Failure: Pathogenesis and Novel Therapeutic Approaches
por: de Lucia, Claudio, et al.
Publicado: (2019)

Deletion of the Innate Immune NLRP3 Receptor Abolishes Cardiac Ischemic Preconditioning and Is Associated with Decreased Il-6/STAT3 Signaling
por: Zuurbier, Coert J., et al.
Publicado: (2012)

Plasma extracellular vesicle proteins are associated with stress-induced myocardial ischemia in women presenting with chest pain
por: Dekker, Mirthe, et al.
Publicado: (2020)

Direct cardiac effects of SGLT2 inhibitors
por: Chen, Sha, et al.
Publicado: (2022)

Employment of Veratria in Acute Diseases of the Chest
Publicado: (1860)

Extracellular traps derived from macrophages, mast cells, eosinophils and neutrophils are generated in a time‐dependent manner during atherothrombosis
por: Pertiwi, Kartika R, et al.
Publicado: (2019)

Quantitative T(2)(*) assessment of acute and chronic myocardial ischemia/reperfusion injury in mice
por: Aguor, Eissa N. E., et al.
Publicado: (2012)

The role of HIFs in ischemia-reperfusion injury
por: Howell, Neil J, et al.
Publicado: (2014)

Closed-loop automated critical care as proof-of-concept study for resuscitation in a swine model of ischemia–reperfusion injury
por: Patel, Nathan T. P., et al.
Publicado: (2022)

Mesenchymal stromal cells in renal ischemia/reperfusion injury
por: de Vries, Dorottya K., et al.
Publicado: (2012)

Transmural ischemia visualized using routine Chest CTA()
por: van Driest, F.Y., et al.
Publicado: (2022)

Ischemia-Selective Cardioprotection by Malonate for Ischemia/Reperfusion Injury
por: Prag, Hiran A., et al.
Publicado: (2022)

Amelioration of endothelial dysfunction by sodium glucose co‐transporter 2 inhibitors: pieces of the puzzle explaining their cardiovascular protection
por: Li, Xiaoling, et al.
Publicado: (2022)

Mitophagy in Cerebral Ischemia and Ischemia/Reperfusion Injury
por: Shen, Luoan, et al.
Publicado: (2021)

TLR9 Mediates Remote Liver Injury following Severe Renal Ischemia Reperfusion
por: Bakker, Pieter J., et al.
Publicado: (2015)

Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na(+)/H(+) exchanger 1: persistent inhibition under various experimental conditions
por: Zuurbier, Coert J, et al.
Publicado: (2021)

Ovarian hormones influence immune response to liver ischemia-reperfusion
por: de Oliveira, T.H.C., et al.
Publicado: (2023)

Characterization of Microparticles after Hepatic Ischemia-Reperfusion Injury
por: Freeman, Christopher M., et al.
Publicado: (2014)

Minimizing Ischemia Reperfusion Injury in Xenotransplantation
por: Patel, Parth M., et al.
Publicado: (2021)

Ischemia-Reperfusion Injury and Anesthesia
por: Zarbock, Alexander, et al.
Publicado: (2014)

Ceramide and Ischemia/Reperfusion Injury
por: He, Xingxuan, et al.
Publicado: (2018)

Ischemia/Reperfusion Injury in Liver Surgery and Transplantation
por: Schemmer, Peter, et al.
Publicado: (2012)

Dynamics of necroptosis in kidney ischemia-reperfusion injury
por: Pefanis, Aspasia, et al.
Publicado: (2023)

Amazonia Phytotherapy Reduces Ischemia and Reperfusion Injury in the Kidneys
por: de Oliveira, Brenner Kássio Ferreira, et al.
Publicado: (2023)

Inhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-Reperfusion
por: Hartman, Minke H. T., et al.
Publicado: (2016)

Mannan-Binding Lectin Is Involved in the Protection against Renal Ischemia/Reperfusion Injury by Dietary Restriction
por: Shushimita, Shushimita, et al.
Publicado: (2015)

A randomized trial of remote ischemic preconditioning and control treatment for cardioprotection in sevoflurane-anesthetized CABG patients
por: Nederlof, Rianne, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_739n7emvlhjgpr8vb6o11brv3g